New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 30, 2014
09:38 EDTFB, NFLX, AAPL, GNW, C, TSLA, MA, AMGN, GILD, TWTRActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL AMZN TWTR NFLX GILD C MA FB RFMD AMGN GNW TSLA
News For MA;AAPL;TWTR;TSLA;NFLX;GILD;C;FB;AMGN;GNW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 >>
August 21, 2015
05:47 EDTNFLX, FBStocks with implied volatility movement; NFLX FB
Subscribe for More Information
August 20, 2015
19:35 EDTFBGoogle tests video ads in search results, Digiday says
Subscribe for More Information
16:48 EDTNFLXOn The Fly: Top stock stories for Thursday
Subscribe for More Information
16:34 EDTGILDGilead MAA for HIV regimen has been fully validated by EMA
Gilead Sciences announced that the company's Marketing Authorization Application, MAA, for an investigational, once-daily single tablet regimen that combines emtricitabine 200 mg, tenofovir alafenamide 25 mg and rilpivirine 25 mg has been fully validated and is now under evaluation by the European Medicines Agency, EMA. Emtricitabine and tenofovir alafenamide are marketed by Gilead Sciences and rilpivirine is marketed by Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The data included in the application support the use of R/F/TAF for the treatment of HIV-1 infection in adults and pediatric patients 12 years and older. "With this validation, R/F/TAF is now the third TAF-based filing under review by the EMA as we advance a portfolio of new treatment options that may offer high efficacy and favorable safety profiles," said Norbert Bischofberger, PhD, Executive Vice President, Research and Development and Chief Scientific Officer, Gilead Sciences. "The R/F/TAF filing also represents the next step in our collaboration with Janssen to develop HIV treatments that potentially meet the diverse needs of people living with HIV."
16:00 EDTFB, AAPL, NFLXOptions Update; August 20, 2015
iPath S&P 500 VIX Short-Term Futures up 1.49 to 17.70. Option volume leaders: AAPL BAC FB NFLX DIS INTC BABA MU
13:26 EDTNFLXOn The Fly: Top stock stories at midday
Subscribe for More Information
12:56 EDTFBSmall drones bringing air traffic problems in U.S., Washington Post reports
Subscribe for More Information
12:24 EDTAAPLVIX methodology for Apple up 12% to 33.29
11:22 EDTNFLXNetflix selling accelerates on heavier volume
Subscribe for More Information
11:16 EDTFB, NFLXStocks with call strike movement; FB NFLX
Subscribe for More Information
11:12 EDTTWTRStocks with call strike movement; MU TWTR
Subscribe for More Information
10:32 EDTFBFacebook August calls active
Facebook August 94 & 95 calls are active on total call volume of 84K contracts (36K puts). August call option implied volatility is at 41, August weekly is at 33, September is at 30; compared to its 52-week range of 20 to 48. Active call volume suggests traders taking positions for upside price movement.
10:22 EDTAAPLApple falls, levels to watch
Subscribe for More Information
10:19 EDTNFLXNetflix may test uptrend support
Subscribe for More Information
09:36 EDTAAPL, FBActive equity options trading on open
Subscribe for More Information
09:17 EDTNFLXDisney hit with another downgrade on TV concerns
Subscribe for More Information
08:45 EDTAAPLApple iPhone 6S may not pressure gross margins, says Bernstein
Subscribe for More Information
06:13 EDTAAPLApple's Australian bonds raise $1.2B within two hours, SMH reports
Subscribe for More Information
06:07 EDTCSamsung Bioepis picks Citi, Goldman as lead managers for IPO, Reuters says
Samsung Bioepis has selected Citigroup (C) and Goldman Sachs (GS) as the lead managers for its planned listening on Nasdaq next year, a source tells Reuters. Morgan Stanley (MS) and Credit Suisse (CS) will also take part in the listing for Samsung's (SSNLF) biosimilar drug development arm, the source says. Reference Link
06:07 EDTAAPLApple's 12.9-inch iPad to feature displays from Sharp, DigiTimes reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use